» Articles » PMID: 10364520

MEFV-Gene Analysis in Armenian Patients with Familial Mediterranean Fever: Diagnostic Value and Unfavorable Renal Prognosis of the M694V Homozygous Genotype-genetic and Therapeutic Implications

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1999 Jun 12
PMID 10364520
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Familial Mediterranean fever (FMF) is a recessively inherited disorder that is common in patients of Armenian ancestry. To date, its diagnosis, which can be made only retrospectively, is one of exclusion, based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery. Renal amyloidosis, prevented by colchicine, is the most severe complication of FMF, a disorder associated with mutations in the MEFV gene. To evaluate the diagnostic and prognostic value of MEFV-gene analysis, we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic-linkage analysis. Eight mutations, one of which (R408Q) is new, were found to account for 93% of the 163 independent FMF alleles, with both FMF alleles identified in 89% of the patients. In several instances, family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype. The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis, compared with other genotypes (P=.0002 and P=.006, respectively). The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families.

Citing Articles

Heterozygous MEFV Mutation Leading to Renal Failure: A Case Study.

El Gazzane S, Ichane A, Nahi C, Mouaddine K, Chkirate B, Guennoun A Glob Pediatr Health. 2024; 11:2333794X241274752.

PMID: 39219559 PMC: 11363043. DOI: 10.1177/2333794X241274752.


E148Q variant: a familial Mediterranean fever-causing mutation or a sequence variant?.

Orouk Awaad E, Khoury L, van Straalen J, Miller-Barmak A, Gazitt T, Haddad-Haloun J Eur J Pediatr. 2024; 183(10):4499-4506.

PMID: 39143349 PMC: 11413036. DOI: 10.1007/s00431-024-05690-5.


Frequency of Familial Mediterranean Fever Gene Mutation in Patients Presenting With Joint Pain and Diagnosed With Acute Rheumatic Fever.

Gullu U, Balaban I, Kara S, Yarali O, Turkyilmaz A, Ipek S Cureus. 2023; 15(8):e43001.

PMID: 37671203 PMC: 10476970. DOI: 10.7759/cureus.43001.


An Update on Familial Mediterranean Fever.

Lancieri M, Bustaffa M, Palmeri S, Prigione I, Penco F, Papa R Int J Mol Sci. 2023; 24(11).

PMID: 37298536 PMC: 10253709. DOI: 10.3390/ijms24119584.


A recurrent side-changing febrile pleural effusion revealing familial Mediterranean fever: a case report.

Mejri I, Saidane A, Boubaker N, Mhamdi S, Daboussi S, Aichaouia C Pan Afr Med J. 2023; 43:121.

PMID: 36762168 PMC: 9883795. DOI: 10.11604/pamj.2022.43.121.33324.


References
1.
SOHAR E, Gafni J, Pras M, Heller H . Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967; 43(2):227-53. DOI: 10.1016/0002-9343(67)90167-2. View

2.
Blum A, Gafni J, SOHAR E, SHIBOLET S, Heller H . Amyloidosis as the sole manifestation of familial Mediterranean fever (FMF). Further evidence of its genetic nature. Ann Intern Med. 1962; 57:795-9. DOI: 10.7326/0003-4819-57-5-795. View

3.
Dinarello C, Wolff S, GOLDFINGER S, Dale D, Alling D . Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med. 1974; 291(18):934-7. DOI: 10.1056/NEJM197410312911804. View

4.
Zemer D, Pras M, SOHAR E, Modan M, Cabili S, Gafni J . Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med. 1986; 314(16):1001-5. DOI: 10.1056/NEJM198604173141601. View

5.
Patarca R, Freeman G, Schwartz J, Singh R, Kong Q, Murphy E . rpt-1, an intracellular protein from helper/inducer T cells that regulates gene expression of interleukin 2 receptor and human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1988; 85(8):2733-7. PMC: 280073. DOI: 10.1073/pnas.85.8.2733. View